ArticleCancer immunology, immunotherapy : CII2006

Dendritic cells engineered to express CD40L continuously produce IL12 and resist negative signals from Tr1/Th3 dominated tumors.

Angelica Loskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.